Chrono group stock price today
WebThe price of Chrono.tech has fallen by 4.66% in the past 7 days. The price declined by 1.27% in the last 24 hours. In just the past hour, the price grew by 1.37%. The current … WebReal time Cronos Group (CRON) stock price quote, stock graph, news & analysis. Cronos Group (CRON) Stock Price, News & Info The Motley Fool. Please ensure …
Chrono group stock price today
Did you know?
WebApr 12, 2024 · See the latest Quantum Exponential Group PLC stock price (AQSE:QBIT), related news, valuation, dividends and more to help you make your investing decisions. WebStock analysis for Cronos Group Inc (CRON:Toronto) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebJun 12, 2024 · Customers Total Raised $204.58M Investors Count 7 Funding, Valuation & Revenue 4 Fundings Chrono24's latest funding round was a Series C for $117.32M on August 11, 2024. View all funding This profile has not been claimed. You're more than your latest funding, tell our customers your company's story. Submit Your Analyst Briefing … WebIn-depth view of key statistics and finances for CRONOS GROUP INC. (CRON) on MSN Money. ... Stock Picks. Today's 52-Week Highs; Today's 52-Week Lows; ... NLS Real …
Web102 rows · Apr 11, 2024 · Cronos Group Inc. (CRON) Stock Historical Prices & Data - Yahoo Finance Nasdaq Futures Russell 2000 Futures (+0.25%) Crude Oil … Find the latest Cronos Group Inc. (CRON) stock discussion in Yahoo Finance's … Get the detailed quarterly/annual income statement for Cronos Group Inc. … Holder Shares Date Reported % Out Value; ETF Managers Tr-EFTMG Alternative … Find out all the key statistics for Cronos Group Inc. (CRON), including valuation … Cronos Group Inc. (CRON) NasdaqGM - NasdaqGM Real Time Price. Currency … Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. … See Cronos Group Inc. (CRON) stock analyst estimates, including earnings … WebShares Out 242.98M 10 Day Average Volume 1.70M Dividend 2.56 Dividend Yield 3.49% Beta 1.27 YTD % Change -12.51 RATIOS/PROFITABILITY EPS (TTM) 18.82 P/E (TTM) …
WebThe live Chrono.tech price today is $36.73 USD with a 24-hour trading volume of $422,902 USD. We update our TIME to USD price in real-time. Chrono.tech is down 2.27% in the last 24 hours. The current CoinMarketCap ranking is #578, with a live market cap of $26,083,991 USD.
WebStock Market Activity Today & Latest Stock Market Trends Nasdaq U.S. After Hours - Market Opens in 13H 38M Market Activity Find a Symbol Use Screener U.S. Major Indexes NASDAQ Composite... chronic graft vs host disease symptomsWebApr 12, 2024 · In Q1 2024 Spinach® ranked in the top-10 in all categories it participated in: Flower, Pre-rolls, Vapes and Edibles. TORONTO, April 12, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is pleased to announce its expanded infused pre-roll offerings … chronic graft versus host disease prognosisWebFeb 18, 2024 · Latest Cronos Group News: View CRON news and discuss market sentiment with the investor community on Public.com. ... Cannabis Watch: Cannabis companies pivot to debt to raise capital as stock prices lag. Market Watch • 02/03/22. Alan Brochstein On Cannabis Investing In 2024 (Video Transcript) chronic granular pharyngitis symptomsWebFind the latest Citigroup Inc. (C) stock quote, history, news and other vital information to help you with your stock trading and investing. chronic granular pharyngitis causesWebFeb 3, 2024 · Cronos Group Inc. Common Share (CRON) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. chronic granular myringitisWebGet the latest Lucid Group Inc (LCID) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. chronic graft versus host disease symptomsWebApr 12, 2024 · 3 analysts have issued 1 year target prices for Cronos Group's stock. Their CRON share price forecasts range from C$3.19 to C$7.00. On average, they expect the company's stock price to reach C$4.71 in the next twelve months. This suggests a possible upside of 90.1% from the stock's current price. View analysts price targets for CRON or … chronic granular pharyngitis